Merck and Moderna Secure Breakthrough in mRNA Cancer Vaccine Trial

By Andrew Joseph · STAT News · 2026-10-25

STAT News reports that a pivotal clinical trial has validated the use of customized mRNA treatments in oncology. By pairing the bespoke vaccine intismeran with the checkpoint inhibitor Keytruda, researchers achieved a significant reduction in the risk of death or recurrence for m

STAT News reports that a pivotal clinical trial has validated the use of customized mRNA treatments in oncology. By pairing the bespoke vaccine intismeran with the checkpoint inhibitor Keytruda, researchers achieved a significant reduction in the risk of death or recurrence for m